211 related articles for article (PubMed ID: 34918882)
1. Determination of serum vascular endothelial growth factor (VEGF) and VEGF receptor levels with VEGF gene polymorphisms in patients with Behçet's uveitis.
Sertoglu E; Yücel Ç; Omma A; Hayran Y; Colak S; Sandıkçı SC; Durukan AH; Ozgurtas T
Adv Clin Exp Med; 2022 Mar; 31(3):231-240. PubMed ID: 34918882
[TBL] [Abstract][Full Text] [Related]
2. The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease.
Sertoglu E; Omma A; Yucel C; Colak S; Sandıkcı SC; Ozgurtas T
Scand J Clin Lab Invest; 2018 Oct; 78(6):443-449. PubMed ID: 30015524
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the relationship of lymphangiogenesis markers with disease pathogenesis in patients with Behçet's uveitis.
Özgürtaş T; Yücel Ç; Sertoğlu E; Hayran Y; Çolak S; Tekgöz E; Omma A; Durukan AH
Acta Clin Belg; 2022 Apr; 77(2):387-395. PubMed ID: 33629934
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor gene polymorphisms in Behçet's disease.
Salvarani C; Boiardi L; Casali B; Olivieri I; Cantini F; Salvi F; Malatesta R; La Corte R; Triolo G; Ferrante A; Filippini D; Paolazzi G; Sarzi-Puttini P; Nicoli D; Farnetti E; Chen Q; Pulsatelli L
J Rheumatol; 2004 Sep; 31(9):1785-9. PubMed ID: 15338501
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor gene polymorphisms and serum levels in Behçet's disease.
Kamoun M; Houman MH; Hamzaoui A; Hamzaoui K
Tissue Antigens; 2008 Dec; 72(6):581-7. PubMed ID: 19054372
[TBL] [Abstract][Full Text] [Related]
6. The Evaluation of the Relationship between sTREM-1, VEGF-B, and VEGF Gene Expression Levels with Disease Activity of Behçet's Patients.
Harmanci K; Akan OY; Pirildar T; Ortan P; Ulman C
Dis Markers; 2018; 2018():2649392. PubMed ID: 30420902
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin Associated and SH3 Domain Containing B (UBASH3B) Gene Association with Behcet's Disease in Iranian Population.
Shahriyari E; Bonyadi M; Jabbarpoor Bonyadi MH; Soheilian M; Yaseri M; Ebrahimiadib N
Curr Eye Res; 2019 Feb; 44(2):200-205. PubMed ID: 30289285
[TBL] [Abstract][Full Text] [Related]
8. The relationship between serum levels of angiogenin, bFGF, VEGF, and ocular involvement in patients with Behçet's disease.
Yalçındağ A; Gedik-Oğuz Y; Yalçındağ FN
Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1807-12. PubMed ID: 23553285
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome.
Cekmen M; Evereklioglu C; Er H; Inalöz HS; Doganay S; Türköz Y; Ozerol IH
Int J Dermatol; 2003 Nov; 42(11):870-5. PubMed ID: 14636202
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.
Robak E; Sysa-Jedrzejewska A; Robak T
Mediators Inflamm; 2003 Oct; 12(5):293-8. PubMed ID: 14760936
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease.
Erdem F; Gündoğdu M; Kiki I; Ali Sari R; Kiziltunç A
Rheumatol Int; 2005 Oct; 25(8):599-603. PubMed ID: 15257411
[TBL] [Abstract][Full Text] [Related]
13. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
[TBL] [Abstract][Full Text] [Related]
14. Value of hematological indices versus VEGF as biomarkers of activity in Behçet's disease.
Gheita TA; Sakr BR; Rabea RE; Abd ElHamid SM
Clin Rheumatol; 2019 Aug; 38(8):2201-2210. PubMed ID: 30919148
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.
Becker J; Pavlakovic H; Ludewig F; Wilting F; Weich HA; Albuquerque R; Ambati J; Wilting J
Clin Cancer Res; 2010 Mar; 16(5):1431-41. PubMed ID: 20179233
[TBL] [Abstract][Full Text] [Related]
16. Aqueous humor IL-8, IL-10, and VEGF levels in Fuchs' uveitis syndrome and Behçet's uveitis.
Simsek M; Cakar Ozdal P; Akbiyik F; Citirik M; Berker N; Ozdamar Erol Y; Yilmazbas P
Int Ophthalmol; 2019 Nov; 39(11):2629-2636. PubMed ID: 31065903
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium.
Kaza E; Ablasser K; Poutias D; Griffiths ER; Saad FA; Hofstaetter JG; del Nido PJ; Friehs I
Cardiovasc Res; 2011 Feb; 89(2):410-8. PubMed ID: 20935166
[TBL] [Abstract][Full Text] [Related]
18. Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease.
Wieczór R; Gadomska G; Ruszkowska-Ciastek B; Stankowska K; Budzyński J; Fabisiak J; Suppan K; Pulkowski G; Rość D
J Zhejiang Univ Sci B; 2015 Nov; 16(11):948-56. PubMed ID: 26537213
[TBL] [Abstract][Full Text] [Related]
19. The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity.
Kwinta P; Bik-Multanowski M; Mitkowska Z; Tomasik T; Pietrzyk JJ
Graefes Arch Clin Exp Ophthalmol; 2008 Oct; 246(10):1467-75. PubMed ID: 18546007
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of assessing VEGF and soluble receptors sVEGFR-1 and sVEGFR-2 in women with breast cancer.
Thielemann A; Baszczuk A; Kopczyński Z; Kopczyński P; Grodecka-Gazdecka S
Ann Agric Environ Med; 2013; 20(2):293-7. PubMed ID: 23772579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
